Nicotine / THR - Statements from Experts: Difference between revisions

Safer nicotine wiki Tobacco Harm Reduction
Jump to navigation Jump to search
Line 109: Line 109:
<br>
<br>


===Professor Dr Michael Kunze===
===Professor Michael Kunze, MD===
*Head of the Institute for Social Medicine, Medical University of Vienna, Austria
*[https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2016/news-in-october-2016/michael-kunze-elected-to-board-of-directors-of-the-european-association-of-professors-emeriti/?L=3Oswald Photo and Bio] / [https://ec.europa.eu/health/archive/ph_overview/documents/refl/ev20041015_co_058_en.pdf Quote Source]
[https://www.clivebates.com/documents/TimmermansSnusJune2017.pdf Source of name]
<br>
[[file:Austria Michael Kunze MD.png|center]]
<br>
<br>


===Bernhard-Michael Mayer, PhD===
===Bernhard-Michael Mayer, PhD===

Revision as of 19:55, 8 February 2023

A picture of scientific notes, chemical formula with the words "THR Statements from Experts. Statements: Medical Professionals, Scientists, Tobacco Control etc"
Statements From Experts


Scientists, Professors, Medical Professionals, Tobacco Control and Public Health Leaders, along with Lawmakers are speaking out in support of adult use of Tobacco Harm Reduction (THR) products to help people quit smoking and to prevent relapse.



Afghanistan

Attaullah Ahmadi

  • notes from an email
  • Attaullah Ahmadi is a Medical Doctor from Afghanistan. He is currently pursuing his MPH with a focus on Epidemiology and Biostatistics at the École des Hautes Études en Santé Publique (EHESP) in France Attaullah Ahmadi is the senior advisor to Global Health Focus (GHF), a network of academics and researchers who seek to achieve health for all. He is also a member at Youth Editorial Board of Public Health Challenges (a Wiley journal). He has served as the GHF Director of Research for Asia and also as a Research Associate at the Medical Research Center of Kateb University. Attaullah Ahmadi seeks to address health inequities and has published many scientific papers on various health topics in developing countries including Afghanistan, analyzing their health systems and highlighting the challenges they face.


Argentina

Dr. Guillermo Eduardo Harvey

Oncological Surgeon. Professor of the first chair of Surgery UNNE. Member of the Argentine Academy of Medicine.



Silvia Inchaurraga. PHD.

psychologist. Director of the Center for Advanced Studies on drug addiction and AIDS at the National University of Rosario.



Milton Klun

Pharmacist, Universidad Nacional del Sur.



Dr. Diego Verrastro


Argentina Dr. Diego Verrastro "Quitting smoking can be hard. Vaping is one more way to quit smoking by getting nicotine with fewer toxins that come from the combustion of tobacco. You can be social, spend less, and once you quit, you'll feel better about it"
Argentina Dr. Diego Verrastro


Australia

Ron Borland PhD

Quote Source / Bio and Photo

Ron Borland PhD "The good intentions of many in tobacco control of trying to limit low toxin alternatives to smoking are in all likelihood paving the way to the hell of prolonging the epidemic of smoking- caused harm."
Ron Borland PhD


Coral Gartner, PhD


Coral Gartner, PhD, School of Public Health Faculty of Medicine Queensland University: "Banning non-therapeutic nicotine vaping products is ethically problematic, because it denies addicted smokers access to a less harmful alternative product and an additional means of quitting smoking."
Coral Gartner, PhD


Wayne Hall, PHD

Quote Source / Bio and Photo

Wayne Hall PhD "A MORE BALANCED AND SENSIBLE PUBLIC HEALTH POLICY WOULD ALLOW [PEOPLE WHO SMOKE] TO ACCESS E-CIGARETTES IN WAYS THAT MINIMISE YOUTH UPTAKE AND MAXIMISE THE POTENTIAL FOR E-CIGARETTES TO ELIMINATE THE GLOBAL USE OF TOBACCO PRODUCTS"
Wayne Hall PhD


Senator Hollie Hughes


Dr Brad Mackay



Colin Mendelsohn, MB BS


Dr Colin Mendelsohn "Vaping can be used as a short term quitting aid or as a long-term strategy to avoid going back to smoking and is at least 95% safer than smoking"
Dr Colin Mendelsohn


Fiona Patten MP


Kathryn Steadman, PhD


Kathryn Steadman, PhD, Associate Professor, School of Pharmacy, Faculty of Health and Behavioural Sciences, The University of Queensland: "The greater barriers to accessing NVPs [nicotine vapor products] than cigarettes are a strong disincentive to switching from cigarettes to NVPs."
Kathryn Steadman, PhD, Associate Professor, School of Pharmacy, Faculty of Health and Behavioural Sciences, The University of Queensland


Judith Watt

Former Executive Director, NCD Alliance - Former Director, Quit Victoria,


Dr. Alex Wodak AM


Dr Alex Wodak AM "Opposition to reduced risk nicotine options inevitably protects the smoking of tobacco which is responsible for the deaths of over half of long term smokers. Vaping is now not only the world's most popular stop smoking aid, but the most effective"
Dr Alex Wodak AM


Austria

Ernest Groman, MD


Ernest Groman MD "The data show the abstinence approach is inadequate. The soulution for smokers is to switch to less harmful alternatives"
Ernest Groman MD


Professor Michael Kunze, MD



Bernhard-Michael Mayer, PhD

Professor of Pharmacology and Toxicology Institute of Pharmaceutical Sciences Karl-Franzens-Universität Graz Austria


Belgium

Karolien Adriaens, PhD


Karolien Adriaens PhD Faculty of Psychology and Educational Sciences, KU Leuven, Belgium "Banning flavoured e-cigarettes will discourage smokers from switching, witch leads to the unintended consequences of continuous and prolonged smoking"
Karolien Adriaens


Frank Baeyens, PhD


Frank Baeyens PhD Professor of Psychology, KU Leuven Belgium "Vaping is significantly less harmful than smoking" "E-cigarettes are a valuble tool for many smokers to help them quit smoking" "Regular vaping in non smokeres is rare and there is no evidence of a 'gateway effect' from vaping to smoking" "WHO's stance on THR is anti scientific, morally reprehensible and diametrically opposed to it's primary mission: it costs lives rather than saving them"
Frank Baeyens


Brazil

Silvia Cazenave. PHD.

PHD in Toxicology and Master in Toxicological Analysis.



Monica Gorgulho

Clinical psychology. Masters in Social Psychology. University of São Paulo, Brazil. Harm Reduction Specialist.



Canada

Michael Chaiton



Patrick Fafard, PhD

Full Professor Centre for Health Law, Policy, and Ethics Graduate School of Public and International Affairs University of Ottawa



Kellie Ann Forbes BScN

Here

Amelia Howard, Sociologist



Ian Irvine, PhD


Ian Irvine PhD Professor of Economics at Concordia University, research fellow at the C.D. Howe Institute "The federal government is currently proposing to place very severe restrictions on the vaping market in the form of nicotine content limits and flavour bans. It should be wary of killing the cigarette extinguishing golden goose."
Ian Irvine PhD


Martin Juneau MPs, MD, FRCP(C)


Martin Juneau MPs, MD, FRCP(C) "In recent years electronic cigarettes have emerged as a valid alternative to tobacco cigarettes to reduce the harmful effects of smoking on health."
Martin Juneau MPs, MD, FRCP(C)


Chris Lalonde, PhD


Chris Lalonde PhD "To the extent that you make vaping less accessible, less affordable, then you're going to prevent the very people who are the most likely to benefit from it from accessing it. What kind of government and what kind of science, would support that? It turns out we're living it."
Chris Lalonde PhD


Clifford Garfield Mahood, O.C.

Founding Executive Director (1976-2012) Non-Smokers’ Rights Association Toronto Canada



Dr John Oyston



David Sweanor, JD

Quote Source / Bio and Photo

David Sweanor JD, Policy and Ethics Ajdunct Proffesor, Faculty of Law, University of Ottawa "Ensuring that a range of low-risk alternatives are not only on the market but have regulatory and tax advantages over cigarettes has the potential to transform public health. We have long known people smoke for nicotine but die from the smoke. Cigarette smoking is a public health catastrophe that can be massively reduced through science and technology if policies can be oriented toward replacing rather than protecting the cigarette business"
David Sweanor JD


Neda Debassige Toeg, BSP, RPh


Neda Debassige Toeg, BSP, RPh, President Aboriginal Pharmacists Association of Canada: "My concern is that harm reduction tools and awareness about alternatives to cigarette use are not available to First Nations" "When given the option to reduce the incidences of smoking , I believe we can substantially reduce overall health risks to First Nations – especially at a time when our people are more vulnerable to harm than the majority of non-First Nations"
Neda Debassige Toeg BSP RPh, President Aboriginal Pharmacists Association of Canada


Mark Tyndall MD ScD FRCPC


Mark Tyndall, Founder of My Safe Society “Around 2012 I heard about vaping. This was the very definition of harm reduction: taking an inherently risky activity and making it way less risky. … The amazing thing about vaping was that for many people, it was even more attractive and satisfying than cigarettes.” “Yet eight years later, who would have thought that throwing a lifeline to people who smoke cigarettes would be so contentious? It should have been a slam-dunk. By now, leading public health authorities around the world should have launched global campaigns to rid the world of cigarettes through vaping. But that just hasn’t happened.”
Mark Tyndall, Founder of My Safe Society


Chile

Hernán Prat Martorell, MD, PhD

Professor at the University of Chile. Former Director of the Cardiovascular Department of the Clinical Hospital of the University of Chile. Former president of the Chilean Society of Hypertension.



Alejandro Erices Ocampo. PHD

Biochemist – Doctor of Science – Post-doctorate in Neurosciences.



Daniel Kleiman Priewer. MD.

Specialist in Traumatology - Orthopedics. Sports injuries. Joint Preservation and Osteoarthritis.



Colombia

Dr. Ramon Calderon

Brazil, Colombia, Spain and Mexico - Doctor in medicine. Plastic Surgeon



Dr. Ana Maria Diaz

PhD in Bioethics.



Hugo Caballero Durán, MD

Former president of the Colombian Society of Pneumology. Former Clinical Scientific Director of Marly Clinic. Director of the Pneumology and Respiratory Therapy Service, Marly Clinic Bogotá, Colombia



Costa Rica

Dr. Randall Rodríguez Obando.

Doctor in medicine. Specialist in Harm Reduction in patients with HIV.



Czech Republic

Pavel Bém MD

Member of the Global Commission on Drug Policy Head of the Clinical Department, Adictology Clinic, Charles University Former Mayor of Prague Member of The National Drug Commission Office of the Government of the Czech Republic


Eva Králíková, MD

Professor Institute of Hygiene and Epidemiology Centre for Tobacco-Dependence First Faculty of Medicine and General Hospital Charles University Prague Czech Republic


Democratic Republic of the Congo

Samuel Mukandi, BA



Ecuador

Dr. Pablo Gallo

Ecuador and Spain - Doctor of Medicine and vascular surgeon specialized in the study and treatment of both arterial pathology and venous pathology and, above all, pelvic venous pathology



César Paz y Miño, MD, PhD

Director, Centro de Investigacion Genética y Genómica and Specialist in Genetics and Human Molecular Biology Universidad UTE Quito, Ecuador



Tanya Soria. MD.

Clinical Oncologist.



Enrique Teran, MD, PhD

Professor College of Health Sciences - Universidad San Francisco de Quito. Ecuadorian Academy of Medicine Academy of Science of Ecuador Ecuador



Francisco E. Urrestra. MD.

Medical Director Hospital Clinica Metropolitana. Ibarra.



El Salvador

Dr. Edward Wollants

Internist and nutritionist.



England/(UK)

Adam Afriyie, BSc


Adam Afriyie, BSc, Chair of Parliamentary Office Science and Technology "Around 50% Medical Practitioners didn't know smoking was more harmful than vaping"
Adam Afriyie, BSc, Chair of Parliamentary Office Science and Technology


Sanjay Agrawal, MD, MBChB


Sanjay Agrawal MD, Professor of Respiratory medicine University Leicester, Chair of Royal Collage Physicians Tobacco Advisory Group: "We want to make e-cigarettes attractive to smokers who are trying to quit. That's the point. For many people, adding flavours, and taking away the taste of tobacco is quite helpful"
Sanjay Agrawal MD, Professor of Respiratory medicine University Leicester, Chair of Royal Collage Physicians Tobacco Advisory Group


Deborah Arnott


Deborah Arnott, MBA, CEO ASH-UK “There are people in the public health community who are obsessed by e-cigarettes” "That because there is so much bad publicity about them, people’s understanding about the relative risk of smoking and e-cigarettes is being undermined. The risk is that smokers who could potentially use these as an alternative to smoking are being discouraged, and that’s not a good thing.” "Do you want the tobacco industry to carry on making cigarettes which are highly addictive and kill when used as intended, or do you want them to move to a product which is much nearer licensed nicotine replacement therapy and is unlikely to kill anyone?”
Deborah Arnott, MBA, CEO ASH-UK


Prof Paul Aveyard


Clive Bates

Quote Source / Bio and Photo / Follow on Twitter


Emma V Beard



John Britton, MD

Quote Source / Bio and Photo

John Britton, MD, Director UK Center For Tobacco and Alcohol Studies, Professor of Epidemiology University Nottingham "Health policy should be driven by science, not prejudice or dogma. Vaping has already provided an effective gateway out of smoking for millions of people, unequivocally benefiting individual smokers, public health and wider society."
John Britton, MD, Director UK Center For Tobacco and Alcohol Studies, Professor of Epidemiology University Nottingham


Dr Leonie Brose


Sharon Cox, PhD



Lynne Dawkins, PhD

  • Quote Source / Bio and Photo / Follow on Twitter
  • Disclosures: I have provided consultancy for the pharmaceutical industry relating to the development of smoking cessation products. I have no conflicts with respect to the tobacco or e-cigarette industry.



Martin Dockrell


Dr Matthew Evison



Jonathan Fell



Floe Foxon, BSc



Suzi Gage



Stuart Griffiths, PhD


Stuart Griffiths, PhD, Director of Research, Services, and Policy, Yorkshire Cancer Research: "When it comes to helping people quit for good, being able to offer vaping products is essential. They are an incredibly effective aid in helping people give up cigarettes.”
Stuart Griffiths, PhD, Director of Research, Services, and Policy, Yorkshire Cancer Research


Peter Hajek, PhD



David Halpern

  • We should deliberately seek to make e-cigs widely available, and to use regulation not to ban them but to improve their quality and reliability.
  • Quote Source


Benjamin Human

Source of name

Sarah Jackson, PhD, MSc



Martin Jarvis ODE, PhD

Quote Source / Bio and Photo


Patricia Kovacevic, JD



Sir Norman Lamb

Graphics Source / Follow on Twitter


Rosemary Leonard, MBE, MA, MB, BChir, MRCGP, DRCOG

Quote Source / Bio / Follow on Twitter


Olivia M Maynard, PhD

Senior Lecturer, School of Psychological Science Bristol Population Health Science Institute MRC Integrative Epidemiology Unit Bristol, United Kingdom


Jim McManus, OCDS, FFPH

Jim McManus, Director of Public Health, Hertfordshire: How and why I changed my mind on e-cigarettes,


Ann McNeill, PhD


Dr Peter Miller

  • Chief Executive of Leicestershire Partnership Trust
  • Quote Source
  • “We understand that stopping smoking can cause discomfort, and have put in place a number of initiatives to support people to not smoke while on our premises, or ideally give up for good. This includes the provision of nicotine replacement therapy and, if required, products for vaping. Whilst we are not there yet, we are committed to continuing on this journey to be smokefree


Marcus Munafò, PhD

Professor of Biological Psychology and MRC Investigator MRC Integrative Epidemiology Unit School of Psychological Science University of Bristol United Kingdom


Dr Kevin Murphy


John Newton, FRCP FFPH FRSPH

Quote Source / Bio


Caitlin Notley, PhD



David Nutt DM, FRCP, FRCPsych, FSB, FMedSci

Quote Source / Bio and Photo / Follow on Twitter


Dr. Sudhanshu Patwardhan

Snus Forum Interview


Debbie Robson, PhD


Louise Ross



Dr Kathryn Scott

  • Quote Source
  • chief executive at Yorkshire Cancer Research
  • "Easy and reliable access to vaping products will give more people in Yorkshire the best chance of quitting for good.”


Lion Shahab, PhD CPsychol AFBPsS

  • Quote Source / Bio / Photo / Follow on Twitter
  • Disclosures: LS has received a research grant, honoraria for talks, consultancy and travel expenses to attend meetings and workshops from pharmaceutical companies that make smoking cessation products (Pfizer; Johnson & Johnson). He has never received any funding or other monetary benefits from the tobacco or e-cigarette industry.



Erikas Simonavičius, PhD


Professor Gerry Stimson

  • Follow on Twitter / Quote Source
  • In almost all areas of public health, affected communities are now seen as a vital part of the policymaking process and the same recognition is long overdue in this field. Policymakers need to hear the experiences of people who have switched away from smoking, and take note of how their decisions are likely to impact people’s lives.


Frances Thirlway, PhD, MSc



Dr Russell Thorpe

Quote source


Robert West, PhD

Professor Emeritus in Health Psychology, University College London


France

Marion Adler, PhD

Smoking Cessation Specialist Hôpital Antoine Béclère Clamart France


Philippe Arvers, MD, PhD

Tobaccologist ans addictologist Université Grenoble Alpes France


Professor Bertrand Dautzenberg



Jacques Le Houezec, PhD



Germany

Peter Liese MEP

Tweet about Peter

Alexander K. Nussbaum, PhD



Dr Ingo Schröder



Dr. F. Artur Schroers



Frank Sitta

tweet about Frank

PROFESSOR HEINO STÖVER



Prof. Dirk Ziebolz



Greece

Konstantinos Farsalinos, MD, MPH

Quote Source / Bio and Photo / Follow on Twitter


Guatemala

Dr Erick Estrada

Family doctor and surgeon. Focused on preventive medicine



Iceland

G. Karl Snæbjörnsson, MD



India

Dr Nimesh Desai



Aparajeet Kar, MD

Consultant Pulmonology and Critical Care Sir H.N Reliance Foundation Hospital Mumbai India


Dr Kiran Melkote, MBBS, MS



Rohan Sequeira, MD, PhD



Ireland

Dr Garrett McGovern



Italy

Pietro Fiocchi

Follow on Twitter / Tweet with info / Quote:


Riccardo Polosa



Umberto Tirelli MD

Professor Director, Cancer Center Clinica Mede Sacile


Japan

Naohito Yamaguchi, MD

Chief of Research Division, Saiseikai Research Institute of Health Care and Welfare Former Professor of Public Health, School of Medicine, Tokyo Women's Medical University


Kenya

Joseph Magero, BBA



Lithuania

Morgana Danielė

video on twitter

Malaysia

Dr Steven Chow

Quote Source / Bio and Photo


Dr Arifin Fii


Shamsul Bahri Mohd Tamrin, PhD

Professor of Occupational Safety and Health/Ergonomics Department of Environmental and Occupational Health University Putra Malaysia Shamsul Bahri Mohd Tamrin, PhD


Mexico

Ldo. Edgar Caballero

Behavioral psychologist



Dr. Jessica Esquivel Chahin

Doctor at the Institute of Minimally Invasive Thoracic Surgery at Hospital Ángeles Lomas. Expert in diagnosis and management of covid-19 patients. Health sciences teacher.



Dr. Jose Alejandro Chavez

Clinical Cardiologist. Member of the Medical Society of the General Hospital of Mexico. Member of the New York Academy of Sciences. USA. Member of the Mexican Society of Cardiology.



Christian Heinrich Henonin MD

MIPH International Public Health. Medical professor, researcher and health consultant Mexico



Dr. José Manuel Mier



Luz Odette Villegas Pichardo. MD

Internal Medicine. South Medical Hospital. Metropolitan Angeles Hospital.



Roberto A Sussman, PhD



Morocco

Imane Kendili MD



New Zealand

PM Jacinda Ardern



Robert Beaglehole, MD, DSc

Ruth Bonita, MPH, PhD, MD (hon)



Julian Buchanan, CPA, DSW, MA, PhD



Marewa Glover, PhD



Deborah Hart LLB



Yolande Jeffares


George Laking, MD, PhD

Chair, End Smoking New Zealand


Dr Murray Laugesen

  • Follow on Twitter
  • “…inhaling mist from the e-cigarette is rated several orders of magnitude (100 to 1000 times) less dangerous than smoking tobacco cigarettes.”
  • Quote Source


Eliana Golberstein Rubashkyn, BSc Pharm, B. Chem



Natalie Walker, PhD

Associate Professor of Population Health and Director of the Centre for Addiction Research, National Institute for Health Innovation, Faculty of Medical and Health Sciences, University of Auckland


Nigeria

ADEBISI Yusuff Adebayo

  • (CASA Board - Africa) Nigeria/UK



Aishat Alaran

  • Follow on Twitter #WomenInTHR

MPhil Candidate at University of Cambridge. Commonwealth Shared Cambridge Trust Scholar. Public Health Researcher

Norway

Karl E Lund, PhD



Pakistan

Dr Ashar Ahmed

Source for name and quote

Peru

Dr Omar Ghiglione

Venezuela, Peru Peripheral Vascular Surgeon.



Philippines

Dr. Rafael R. Castillo



Dr. Fernando Fernandez

Quote Source / Bio / Photo


Arleen R. Reyes, DMD, ICD, ICCDE

Past President, Philippine Dental Association Chairman, Commission on Dental Education Asia -Pacific Dental Federation Philippines


Ron Christian G. Sison, MLS(ASCPi), MPH

Assistant Professor Lead Convenor Harm Reduction Alliance of the Philippines Manila Philippines


Poland

Andrzej Sobczak, PhD

Professor Head of Department of General and Inorganic Chemistry Faculty of Pharmaceutical Sciences in Sosnowiec Medical University of Silesia Katowice Poland


Romania

Mihaela Răescu Phd



Scotland

Prof Linda Bauld, OBE



Dr. Ehsan Latif


South Africa

Dr Kgosi Letlape



Solomon Rataemane



South Korea

Young-bum Park, PhD

Professor Department of Economics Hansung University South Korea


Spain

Manuel Linares Abad, PhD



José Mª García Basterrechea, MD

Associate Professor of Medicine University of Murcia Former head, Addiction and Dual Pathology Unit Reina Sofía Hospital. Spain.



Fernando Fernández Bueno, MD

Oncological surgeon at the Hospital Central de la Defensa Gómez Ulla Professor at the University of Alcalá de Henares Madrid Spain



Carmen Escrig, PhD



Miguel de la Guardia PhD

Professor of Analytical Cemistry University of Valencia Spain



Maria del Mar Sangüesa Jareño, MD

Intensive Care Specialist University Hospital of Ceuta, Spain



José David García Muñiz, MD, PhD

Clinical Pharmacology and Internal Medicine Clinical Trials Coordinator, Principal Investigator University Hospital of Ceuta Spain



Jose Miguel Rodriguez (Gonzalez-Moro)



Antonio Sierra, MD, PhD

Professor of Preventive Medicine and Public Health at the University of La Laguna. Former Dean of the Faculty of Medicine of the University of La Laguna Former General Director of Public Health of the Government of the Canary Islands



Francisco Garcia Sierra, MD.

Head of the Nephrology Service University Hospital of Ceuta Spain



Josep María Ramón Torrell, MD, PhD.

Professor of Epidemiology and Public Health University of Barcelona Head of Clinical Prevention Research Group Bellvitge Biomedical Research Institut Head of Tobacco Prevention Service Bellvitge Hospital Barcelona, Spain



Angel González Ureña, PhD

Emeritus Professor of Physical Chemistry. Complutense University of Madrid



Singapore

Tan Kok Kuan, MD

Medical Director Dr Tan Medical Center Novena Medical Center Singapore


Andrew John da Roza

Psychotherapist - Addictions Promises Health Care Pte. Ltd. Singapore


Sweden

Professor Tony Axéll

  • find quote


Curt Enzell


KARL FAGERSTRÖM PhD



Anders Milton MD, PhD

Quote Source / Bio and Photo


Lars Ramström PhD

Quote Source / Bio and Photo


Switzerland

Gizelle Baker



Jean-François Etter, PhD

Professor of public health Institute of Global Health, Faculty of Medicine University of Geneva


Moira Gilchrist PhD



Tikki Elka Pang, PhD

Former Director, Research Policy & Cooperation, WHO, Geneva Switzerland


Tunisia

Fares Mili MD-CTTS- NCTTP

Quote Source: / Bio and Photo


United Arab Emirates

GOPAL BHATNAGAR, MD


Gopal Bhatnagar, MD, Chief of Cardiac Surgery, Heart and Vascular Institute, Cleveland Clinic, Abu Dhabi. Former Chief of Staff, Trillium Health Centre, Ontario, Canada. Vape Shop Owner: You just don’t victimize smokers twice. You don’t make something that’s hyper-addictive freely available to people and then you victimize them again by saying well you know there’s a technology that has the ability to help you get off this… but we’re going to restrict that.
Gopal Bhatnagar, MD, Chief of Cardiac Surgery, Heart and Vascular Institute, Cleveland Clinic, Abu Dhabi. Former Chief of Staff, Trillium Health Centre, Ontario, Canada. Vape Shop Owner.


Cother Hajat, MBBS PhD FFPH FRCP



United States

David Abrams PhD


David Abrams, PhD, Professor of Social and Behavioral Sciences, New York University School of Global Public Health: "E-cigarettes are substantially less harmful than burning toxic tobacco. They can help some people who have been unable to quit to switch and save their lives. The science in the last 2-3 years has become incredibly strong. It was the science that drove me to change my mind. I think we've forgotten it's the smoker and potential smoker we're supposed to be helping. They're people too. You can't forget that."
David Abrams, PhD, Professor of Social and Behavioral Sciences, New York University School of Global Public Health


Jerome Adams, MD, MPH



Jasjit S Ahluwalia, MD, MPH, MS



Tamar Antin, DrPH, MAA



Alex Azar, JD



Aaron Biebert, BA


File:US Aaron Biebert.png


David J. K. Balfour, DSc



Scott Ballin, JD

  • Photo: Monique Calello / The News Leader
  • Bio: Has served as chairman of the Coalition on Smoking or Health (the precursor to the Campaign for Tobacco-Free Kids); vice president of the American Heart Association; steering committee of the Alliance for Health Economic and Agriculture Development (AHEAD); advisor to the Food and Drug Law Institute’s tobacco conferences; advisor to the University of Virginia's Morven Dialogues on tobacco, nicotine and harm reduction.
  • Statement: Most smokers want to quit and if we can provide those smokers with science based, consumer acceptable lower risk products we could fundamentally alter the current marketplace and save hundreds of thousands of premature deaths.
  • Source: Comments on vaping and tobacco harm reduction from expert stakeholders
    • This year approximately 8 million people will die prematurely from smoking. I am deeply disappointed with what can only be described as an ongoing 'dark ages' approach to tobacco control. While many traditional forms of tobacco control remain useful and effective, little has been done by the WHO and many other mainstream public health organizations to acknowledge and think about how regulation, research, technology and innovation can be collectively harnessed to give the billion addicted cigarette smokers viable science based lower risk products. Science and 'safe-haven' engagement and debate continues to be displaced with polarized thinking that often is more focused on getting media attention than actually finding workable win-win solutions for the good of society.
    • Scott D. Ballin, JD
    • Health Policy Consultant
    • Former Vice President and Legislative Counsel, American Heart Association
    • Former Chairman of the Coalition on Smoking OR Health (AHA, ASCS. ALA)
    • Advisor to the University of Virginia, Institute for and Engagement and Negotiation (The Morven Dialogues)



Neal Benowitz



Chelsea Boyd



Jeffrey Brandes



Thomas Brandon, PhD

  • Earlier this year, the findings from a major clinical trial, published in the New England Journal of Medicine, showed that e-cigarettes were almost twice as effective as the nicotine patch for producing one year of smoking cessation. These findings added to those of other, smaller studies previously published.
  • This could be a game-changer for lots of people,” says Thomas Brandon, Ph.D., director of Moffitt’s Tobacco Research and Intervention Program and chair of the Department of Health Outcomes and Behavior. *“It means that for smokers who have not been able to quit by using the available medications, vaping might be worth a try. But it is important to completely switch from smoking to vaping to get the most health benefits.”
  • Thomas Brandon, PhD, is the Director of the Tobacco Research and Intervention Program and Chair of the Department of Health Outcomes and Behavior at Moffitt Cancer Center. He is also Professor of Psychology and Oncologic Sciences at the University of South Florida
  • SEE: Tweet w/graphic



Susan Cameron, MBA



Richard H Carmona MD, MPH, FACS



Representative Julie A. Casimiro



Suzanne M. Colby, PhD



Kenneth Michael Cummings PhD, MPH



Brittani Cushman (TPB) spelling?

  • (Disclosure)



David Dobbins, JD, MPH



Clifford E. Douglas, J.D



Allan Erickson



Michael Eriksen, ScD



Michael Fiore

  • "In just today, we are going to lose 20 of our residents. Twenty individuals in Wisconsin are going to die prematurely of a disease directly caused by their smoking, on average, robbing them of 10 to 15 years of life." " Many adults don't want children exposed to secondhand smoke. Vaping is, without a question, less dangerous than cigarette smoking."



Steve Forbes

  • Find quote



Jonathan Foulds PhD



Abigail S. Friedman PhD



Stephen F. Gambescia, PhD



Charles A. Gardner, PhD



Karen K Gerlach, PhD, MPH



Joe Gitchell

  • find quote
  • (Disclosures)



Thomas J. Glynn, PhD

Adjunct Lecturer Prevention Research Center School of Medicine, Stanford University Formerly, Associate Director, Cancer Control Science Program, U.S. National Cancer Institute, and Director, Cancer Science and Trends, American Cancer Society



Bill Godshall

Quote Source / Photo Source


Dr. Scott Gottlieb



Marc Gunther



Scott Hadland, MD, MPH, MS, BS



Dorothy K. Hatsukami, PhD



Nan Hayworth, MD



Dr. Cheryl Healton

Founding President and CEO of American Legacy Foundation (created from MSA Funds, now known as the Truth Initiative); Dean of School of Global Public Health and Professor of Public Health Policy and Management, NYU School of Global Public Health; Founding chair of the Public Health Practice Council of the Association of Schools of Public Health; Serves on the National Board of Public Health Examiners, the Betty Ford Institute, Lung Cancer Alliance, Board of Directors at the Association of Schools and Programs of Public Health, and the Board of Directors at HealthRight International. Tobacco Harm Reduction Quote: E-cigarette Summit 2021 We treat addiction to combustible tobacco differently than addiction to other products with respect to harm reduction approaches. We are spending way too much time on infighting and too little time on finding common ground to massively reduce combustible tobacco use and ending the false equivalency between products. Smoking remains a worldwide tragedy causing a billion lives at stake in this century alone. Lower risk products exist to help those unable or unwilling to quit. We have abandoned our harm reduction approach in public health when it comes to saving smokers. Retirement from American Legacy (now Truth)

Matthew Holman, PhD



Matthew Wayne Johnson, Ph.D.

Quote / Bio and Photo


Senator Ron Johnson

  • Wisconsin



Peter Killeen PhD



Jaron Hoani King



Bethea A Kleykamp, MA, PhD

  • Quote Source / Bio and Photo / Follow on Twitter
  • COI: I currently have no conflicts of interest with respect to tobacco, vaping or pharmaceutical industries. From May 2014 to September 2018, I provided harm reduction consulting services to an e-cigarette company (NJOY) and a tobacco company (RJ Reynolds) through my work at Pinney Associates.



Robin Koval



Lynn Kozlowski



Pritika Kumar R-Street

  • find quote


Ted Kyle, RPh, MBA



Jody Lanard MD



Harry A. Lando, PhD



Scott Leischow, PhD



Caryn Lerman, PhD



Alex Liber



Stefani Lord



Dr. Michael Madden



Robin Mermelstein, Ph.D.

Distinguished Professor, Liberal Arts and Sciences Psychology Department Director, Institute for Health Research and Policy Co-Director, Center for Clinical and Translational Science University of Illinois at Chicago



Tom Miller JD




Vivek H. Murthy, MD, MBA



Ethan A Nadelmann

  • Follow on Twitter
  • Source: Comments on vaping and tobacco harm reduction from expert stakeholders
    • It took WHO all too many years to embrace “harm reduction” thinking and policies vis a vis consumers of illicit drugs but it eventually did. Hundreds of thousands, possibly millions of lives, could have been saved if WHO had acted earlier to transcend the political forces and counterproductive ideologies and rhetoric that drove the war on drugs and its insistence on punitive abstinence-only policies.
    • Yet now we see WHO repeating very similar mistakes as it resists and dismisses the technological innovations in tobacco and nicotine products that could radically reduce associated harms to both consumers and society at large. The organization’s leaders need to open their eyes and summon the courage to follow the science, not the politics. Failure to do so may ultimately result in the emergence of an international tobacco/nicotine prohibition regime with all the failures, costs and counter-productive consequences of the failed global drug prohibition regime.
    • Ethan A Nadelmann - Bio and Photo
    • Founder & Former Executive Director (2000-2017)
    • Drug Policy Alliance
    • New York and International



Cam Nereim, MD, FAAP



Paul Newhouse

Quote source "It [nicotine] seems very safe even in nonsmokers. In our studies we find it actually reduces blood pressure chronically. And there were no addiction or withdrawal problems, and nobody started smoking cigarettes. The risk of addiction to nicotine alone is virtually nil."

Raymond S. Niaura, PhD



Joel Nitzkin, MD



Joe Nocera



Amy Nyman, MA



Michael Ogden, Phd



Cheryl K. Olson, Sc.D.



Jason Osborne



Laura Leigh Oyler



Amanda Palmer, PhD



Tommy J Payne, JD



Kenneth A. Perkins, PhD



Michael F. Pesko, PhD



Carl V. Phillips, MPP, PhD



Ovide Pomerleau, PHD



Helen Redmond, LCSW



Vaughan Rees, PhD



Nancy A. Rigotti, MD



Dr. Brad Rodu



Jed Rose (Title?)



Veronique de Rugy, PhD



Sally Satel



Steven A Schroeder, MD



John Seffrin, MD, PhD

Source #1 and Source #2 Bio: Former CEO of the American Cancer Society and ACS Cancer Action Network. Served on the White House Advisory Group on Prevention, Health Promotion, and Integrative and Public Health, as well as the Advisory Committee to the Director of the Centers for Disease Control and Prevention. He also served on the National Cancer Policy Board of the Institute of Medicine and the National Cancer Legislation Advisory Committee. He is a past president of the International Union Against Cancer. He helped to create the National Center for Tobacco-Free Kids (now the Campaign for Tobacco-Free Kids) Source #1 and Source #2 Statement: Technologies/alternatives exist today that can help people quit smoking or at least reduce significantly their consumption of burned tobacco, which is what kills them. After fighting the tobacco epidemic for over 5 decades, we now have proven harm reduction methods to help us avoid a carnage in otherwise preventable deaths.

Arielle Selya, PhD

(need to find a quote)



Michael Siegel

Visiting Professor, Department of Public Health and Community Medicine Tufts University School of Medicine Boston



Robert Sklaroff



Gary E. Swan, PhD



Sheila Vakharia, PhD MSW



Harlan Vincent (NM)

  • find quote


Nora Volkow (Title?)



Carrie Wade, PhD



Kenneth Warner, PhD



Daniel Wikler, Ph.D.

  • need to find quote



Derek Yach, MBChB, MPH, DSc



Mitch Zeller, JD

Bio / Photo Source / Quote Source


Venezuela

Dr Ali M Ayubi MD, MS, PhD.

Head of the Department of Behavioral Sciences and Addictions and Professor of Pharmacology, Behavioral Sciences and Addictions Medical University of the Caribbean Professor Emeritus of Pharmacology and Addiction Diseases of the University of Zulia.



Natasha A. de Herrera, PhD

Clinical Psychology, Centro Medico Docente la Trinidad, Psychiatric Unit, Smoking Cessation Clinic, Caracas



Statements by Multiple Parties

2021: One hundred specialists call for WHO to change its hostile stance on tobacco harm reduction - new letter to FCTC delegates published


2021: Reappraising Choice in Addiction: Novel Conceptualizations and Treatments for Tobacco Use Disorder


2021: 75 Tobacco Control experts ask CDC to change the name of EVALI


2019: Testimony for New York Senate hearing on vaping safety - Clive Bates and David Sweanor


2018: Letter from seventy-two specialists in nicotine science, policy and practice


????: Statement by 28 Medical Professionals in Latin America


Suggestions to add to this page

Spain

It’s combustion in cigarettes that kills, not nicotine

See Letter: The benefits of vaping

CAPHRA Expert Advisory Group

Two from Canada

Delon Human

2023 Dr Ekaterina Netchitailova

2022 LESS HARM: INTERNATIONAL DECLARATION FOR A SMOKE-FREE SPAIN

  • Signed by 170 experts

Doctors, scientists ask Marcos to sign vape bill

French Prime Minister

Maybe organization, too? SMOKING CESSATION: VAPE OR NOT VAPE?

2019 E-cigarettes need to be regulated, not banned: Dr Patrick Basham Read more at: https://health.economictimes.indiatimes.com/news/policy/e-cigarettes-need-to-be-regulated-not-banned-dr-patrick-basham/72392936

expert reaction to Department of Health press release ‘e-cigarettes could be prescribed on the NHS in world first’

E-cig Summit UK 2021 speakers

A New International Commission of Experts Finds the Global Fight Against Smoking Has Stalled

CRUCIAL STEP IN TOBACCO HARM REDUCTION

Canada

expert reaction to WHO report on nicotine and tobacco products

Ending Cigarette Use By Adults In A Generation Is Possible

Letter with names to research

More names to research for positive statements

Comments on vaping and tobacco harm reduction from expert stakeholders

More names on this doc

World No Tobacco Day: Here's why WHO’s approach to tobacco cessation needs an overhaul

The Truth Initiative, too, once embraced harm reduction. Its former board chairman, Tom Miller, Iowa’s long-serving attorney general, still argues that e-cigarettes are a “means to saving millions of lives.” Cheryl Healton, its former CEO, and David Abrams, formerly executive director of the Schroeder National Institute of Tobacco Research and Policy Studies, which is housed at the Truth Initiative, are harm-reduction advocates. So is Steven Schroeder, for whom the institute is named. Found here

72 Statements to WHO

M.O.V.E.

Quotes